123 related articles for article (PubMed ID: 24625442)
1. Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma.
Song H; Pan B; Yi J; Chen L
Exp Biol Med (Maywood); 2014 May; 239(5):529-41. PubMed ID: 24625442
[TBL] [Abstract][Full Text] [Related]
2. Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
Zhao L; He LR; Xi M; Cai MY; Shen JX; Li QQ; Liao YJ; Qian D; Feng ZZ; Zeng YX; Xie D; Liu MZ
J Transl Med; 2012 Dec; 10():249. PubMed ID: 23232108
[TBL] [Abstract][Full Text] [Related]
3. Nimotuzumab, an EGFR‑targeted antibody, promotes radiosensitivity of recurrent esophageal squamous cell carcinoma.
Yu Y; Guan H; Jiang L; Li X; Xing L; Sun X
Int J Oncol; 2020 Apr; 56(4):945-956. PubMed ID: 32319582
[TBL] [Abstract][Full Text] [Related]
4. The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin.
Zhao L; Li QQ; Zhang R; Xi M; Liao YJ; Qian D; He LR; Zeng YX; Xie D; Liu MZ
Tumour Biol; 2012 Aug; 33(4):1115-23. PubMed ID: 22389159
[TBL] [Abstract][Full Text] [Related]
5. The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.
Jia J; Cui Y; Lu M; Wang X; Li J; Li J; Li Y; Zhang X; Gao J; Zhou J; Lu Z; Gong J; Yu J; Sun Z; Liu C; Shen L; Zhang X
Clin Transl Oncol; 2016 Jun; 18(6):592-8. PubMed ID: 26459251
[TBL] [Abstract][Full Text] [Related]
6. Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
Zhan L; Qin Q; Lu J; Liu J; Zhu H; Yang X; Zhang C; Xu L; Liu Z; Cai J; Ma J; Dai S; Tao G; Cheng H; Sun X
Dis Esophagus; 2016 Apr; 29(3):215-23. PubMed ID: 25604309
[TBL] [Abstract][Full Text] [Related]
7. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
8. Overall Survival of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma Treated with Nimotuzumab in the Real World.
Saumell Y; Sanchez L; González S; Ortiz R; Medina E; Galán Y; Lage A
Adv Ther; 2017 Dec; 34(12):2638-2647. PubMed ID: 29134427
[TBL] [Abstract][Full Text] [Related]
9. Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study.
Lai X; Gu Q; Zheng X; Liu G; Feng W; Lin X; Mao W
J Cancer Res Ther; 2016 Oct; 12(Supplement):89-95. PubMed ID: 27721263
[TBL] [Abstract][Full Text] [Related]
10. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
Gu MM; Li M; Gao D; Liu LH; Lang Y; Yang SM; Ou H; Huang B; Zhou PK; Shang ZF
Toxicol Appl Pharmacol; 2018 Jun; 348():76-84. PubMed ID: 29679654
[TBL] [Abstract][Full Text] [Related]
11. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
Qian X; Tan C; Yang B; Wang F; Ge Y; Guan Z; Cai J
Dis Esophagus; 2017 Jun; 30(6):1-7. PubMed ID: 28475750
[TBL] [Abstract][Full Text] [Related]
12. Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer.
Chen Y; Li X; Guo L; Wu X; He C; Zhang S; Xiao Y; Yang Y; Hao D
Mol Med Rep; 2015 Aug; 12(2):1645-52. PubMed ID: 25891159
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells.
González JE; Barquinero JF; Lee M; García O; Casaco A
Cancer Biol Ther; 2012 Jan; 13(2):71-6. PubMed ID: 22231391
[TBL] [Abstract][Full Text] [Related]
14. Sunitinib modulates the radiosensitivity of esophageal squamous cell carcinoma cells in vitro.
Ding YQ; Zhu HC; Chen XC; Sun XC; Yang X; Qin Q; Zhang H; Yang Y; Yang YH; Gao L; Luo JD; Zhou XF
Dis Esophagus; 2016 Nov; 29(8):1144-1151. PubMed ID: 26542732
[TBL] [Abstract][Full Text] [Related]
15. Autophagy inhibition enhances radiosensitivity of Eca‑109 cells via the mitochondrial apoptosis pathway.
Tao H; Qian P; Lu J; Guo Y; Zhu H; Wang F
Int J Oncol; 2018 Jun; 52(6):1853-1862. PubMed ID: 29620258
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced autophagy promotes esophageal squamous cell carcinoma cell survival via the LKB1 pathway.
Lu C; Xie C
Oncol Rep; 2016 Jun; 35(6):3559-65. PubMed ID: 27109915
[TBL] [Abstract][Full Text] [Related]
17. Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cells.
Miyanaga S; Ninomiya I; Tsukada T; Okamoto K; Harada S; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Feb; 48(2):517-24. PubMed ID: 26676807
[TBL] [Abstract][Full Text] [Related]
18. High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.
Wang CY; Deng JY; Cai XW; Fu XL; Li Y; Zhou XY; Wu XH; Hu XC; Fan M; Xiang JQ; Zhang YW; Chen HQ; Perez R; Jiang GL; Zhao KL
Oncotarget; 2015 Jul; 6(21):18674-82. PubMed ID: 26124180
[TBL] [Abstract][Full Text] [Related]
19. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
20. eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma.
Zhu H; Song H; Chen G; Yang X; Liu J; Ge Y; Lu J; Qin Q; Zhang C; Xu L; Di X; Cai J; Ma J; Zhang S; Sun X
Radiother Oncol; 2017 Sep; 124(3):439-447. PubMed ID: 28431753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
